Worldwide Clinical Trials

Worldwide Clinical Trials is a privately held, revenue-generating global CRO offering full-service, functional service provider (FSP), and hybrid clinical trial models. Its core value proposition is deep therapeutic expertise combined with a flexible, client-centric partnership model, recently enhanced by the acquisition of Catalyst Clinical Research to expand oncology capabilities and global reach. The company operates a technology platform aimed at improving study visibility and data transparency, serving sponsors across a wide range of therapeutic areas from its operational hubs worldwide.

Integrated technology platform focused on improving study visibility, data transparency, and decision-making for clinical trial sponsors. Likely encompasses clinical trial management, data capture, and analytics tools.

Competes in the crowded global CRO market against large players (IQVIA, ICON, PPD) and smaller, specialized firms. Differentiates through a mid-sized, personalized service model and deep therapeutic expertise. The acquisition strategy aims to increase scale and capability to compete for larger contracts.